Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 172

    1.

    A randomised, placebo controlled clinical trial of the aldose reductase inhibitor CT-112 as management of corneal epithelial disorders in diabetic patients.

    Nakahara M, Miyata K, Otani S, Miyai T, Nejima R, Yamagami S, Amano S.

    Br J Ophthalmol. 2005 Mar;89(3):266-8.PMID: 15722300 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Aldose reductase inhibitor (CT-112) eyedrops for diabetic corneal epitheliopathy.

    Ohashi Y, Matsuda M, Hosotani H, Tano Y, Ishimoto I, Fukuda M, Manabe R.

    Am J Ophthalmol. 1988 Mar 15;105(3):233-8.PMID: 3125744 [PubMed - indexed for MEDLINE]Related articles

    4.

    Reversal of abnormal corneal epithelial cell morphologic characteristics and reduced corneal sensitivity in diabetic patients by aldose reductase inhibitor, CT-112.

    Hosotani H, Ohashi Y, Yamada M, Tsubota K.

    Am J Ophthalmol. 1995 Mar;119(3):288-94.PMID: 7872388 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effects of aldose reductase inhibitor CT-112 on the corneal epithelial barrier of galactose-fed rats.

    Yokoi N, Niiya A, Komuro A, Yokogaki S, Naka H, Awata T, Honma Y, Yamada J, Tei M, Kinoshita S.

    Curr Eye Res. 1997 Jun;16(6):595-9.PMID: 9192169 [PubMed - indexed for MEDLINE]Related articles

    6.

    Topical aldose reductase inhibitor for correcting corneal endothelial changes in diabetic patients.

    Ohguro N, Matsuda M, Ohashi Y, Fukuda M.

    Br J Ophthalmol. 1995 Dec;79(12):1074-7.PMID: 8562538 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Corneal epithelial barrier function in diabetic patients.

    Gekka M, Miyata K, Nagai Y, Nemoto S, Sameshima T, Tanabe T, Maruoka S, Nakahara M, Kato S, Amano S.

    Cornea. 2004 Jan;23(1):35-7.PMID: 14701955 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effects of topical aldose reductase inhibitor CT-112 on corneal sensitivity of diabetic rats.

    Hosotani H, Ohashi Y, Kinoshita S, Matsumoto T, Awata T.

    Curr Eye Res. 1996 Oct;15(10):1005-7.PMID: 8921238 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effects of aldose reductase inhibition with tolrestat on diabetic retinopathy in a six months double blind trial.

    van Gerven JM, Boot JP, Lemkes HH, van Best JA.

    Doc Ophthalmol. 1994;87(4):355-65.PMID: 7851219 [PubMed - indexed for MEDLINE]Related articles

    10.

    Diabetic-like corneal sensitivity loss in galactose-fed rats ameliorated with aldose reductase inhibitors.

    Jacot JL, Hosotani H, Glover JP, Lois N, Robison WG Jr.

    J Ocul Pharmacol Ther. 1998 Apr;14(2):169-80.PMID: 9572543 [PubMed - indexed for MEDLINE]Related articles

    11.

    Improvement of corneal sensation and tear dynamics in diabetic patients by oral aldose reductase inhibitor, ONO-2235: a preliminary study.

    Fujishima H, Shimazaki J, Yagi Y, Tsubota K.

    Cornea. 1996 Jul;15(4):368-75.PMID: 8776562 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effects of substance P and IGF-1 in corneal epithelial barrier function and wound healing in a rat model of neurotrophic keratopathy.

    Nagano T, Nakamura M, Nakata K, Yamaguchi T, Takase K, Okahara A, Ikuse T, Nishida T.

    Invest Ophthalmol Vis Sci. 2003 Sep;44(9):3810-5.PMID: 12939296 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Effect of an aldose reductase inhibitor, CT-112, on healing of the corneal epithelium in galactose-fed rats.

    Awata T, Sogo S, Yamagami Y, Yamamoto Y.

    J Ocul Pharmacol. 1988 Fall;4(3):195-201.PMID: 3143793 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effects of aldose reductase inhibitor, CT-112, on sugar alcohol accumulation in corneal epithelium of galactose-fed rats.

    Awata T, Sogo S, Yamamoto Y.

    Jpn J Ophthalmol. 1986;30(3):245-50.PMID: 3097363 [PubMed - indexed for MEDLINE]Related articles

    15.

    Ocular surface changes with applanation contact lens and coupling fluid use after argon laser photocoagulation in noninsulin-dependent diabetes mellitus.

    Dogru M, Kaderli B, Gelisken O, Yücel A, Avci R, Goto E, Shimmura S, Shimazaki J, Tsubota K.

    Am J Ophthalmol. 2004 Sep;138(3):381-8.PMID: 15364219 [PubMed - indexed for MEDLINE]Related articles

    16.

    Effect of aldose reductase inhibitor on corneal epithelial barrier function in galactose-fed dogs.

    Kubo E, Mori K, Kobayashi T, Takahashi Y, Yokoi N, Kinoshita S, Kasahara T, Yonezawa H, Akagi Y.

    J Ocul Pharmacol Ther. 1998 Apr;14(2):181-90.PMID: 9572544 [PubMed - indexed for MEDLINE]Related articles

    17.

    A novel grading method for superficial punctate keratopathy magnitude and its correlation with corneal epithelial permeability.

    Miyata K, Amano S, Sawa M, Nishida T.

    Arch Ophthalmol. 2003 Nov;121(11):1537-9.PMID: 14609908 [PubMed - indexed for MEDLINE]Related articles

    18.

    Fluorophotometry as a diagnostic tool for the evaluation of dry eye disease.

    Fahim MM, Haji S, Koonapareddy CV, Fan VC, Asbell PA.

    BMC Ophthalmol. 2006 May 26;6:20.PMID: 16729882 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Effectiveness of hyaluronan on corneal epithelial barrier function in dry eye.

    Yokoi N, Komuro A, Nishida K, Kinoshita S.

    Br J Ophthalmol. 1997 Jul;81(7):533-6.PMID: 9290362 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Morphology and barrier function of the corneal epithelium after penetrating keratoplasty: association with original diseases, tear function, and suture removal.

    Shimazaki J, Shimmura S, Mochizuki K, Tsubota K.

    Cornea. 1999 Sep;18(5):559-64.PMID: 10487430 [PubMed - indexed for MEDLINE]Related articles